Is Women’s Health a Good Investment Opportunity for Private Wealth?
Why Women’s Health Is the Most Mispriced Opportunity in Private Capital Today $124 trillion is transferring to women. Women’s health […]
Why Women’s Health Is the Most Mispriced Opportunity in Private Capital Today $124 trillion is transferring to women. Women’s health […]
How aging populations, rising costs, and institutional inertia quietly reshaped medicine into one of the largest sectors of the modern
Blackstone and TPG’s acquisition of Hologic isn’t just a medtech move. It’s a cultural signal. Here’s what it reveals about
An investor’s view on where distribution power, evidence, and risk are quietly shifting This essay reflects a capital allocator’s perspective